FDA Approved: DALVANCE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Dalvance (dalbavancin) submitted by Allergan, Inc. The action approves a supplemental NDA related to the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Dalvance (dalbavancin)

Snippet

SUPPL AP for DALVANCE (DALBAVANCIN)